Trial Details
TERMINATEDBasic Information
| Clinical ID | c569 |
|---|---|
| Identifier | NCT01375179 |
| Trial Title | Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: KRP203|DRUG: Placebo matching KRP203 |
Participant Information
| Sponsor | Novartis Pharmaceuticals |
|---|---|
| City | Gent |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-12-10 |
|---|---|
| Primary Completion Date | 2025-05-12 |
| Completion Date | 2025-05-12 |